Grandview Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Grandview Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-60	Closed	-$5K	–	427
2021 Q1	$5K	Buy	+60	New	+$5.58K	﹤0.01%	396
2020 Q1	–	Sell	-7,733	Closed	-$466K	–	71
2019 Q4	$466K	Sell	7,733 -1,150	-13%	-$70.9K	0.44%	52
2019 Q3	$497K	Sell	8,883 -1,086	-11%	-$69.3K	0.45%	57
2019 Q2	$643K	Sell	9,969 -1,765	-15%	-$114K	0.6%	45
2019 Q1	$745K	Buy	+11,734	New	+$616K	0.69%	42

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Grandview Asset Management's TNDM Position: Q2 2021 in Review

Grandview Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 60 shares — an estimated $5K sold.

Grandview Asset Management first reported a position in TNDM in Q1 2019 and held it in 5 quarters. The position peaked at $745K in Q1 2019. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

Grandview Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
Grandview Asset Management sold 60 Tandem Diabetes Care shares in Q2 2021, an estimated $5K.
Grandview Asset Management first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 5 quarters.
Grandview Asset Management's Tandem Diabetes Care position peaked at $745K in Q1 2019.
303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Grandview Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.